SNT 2.44% 4.0¢ syntara limited

12 month phase 3 trial finds bronchitol safe, page-3

  1. VVS
    954 Posts.
    lightbulb Created with Sketch. 50
    Mate hold on a minute. I don't think they have even met with the TGA yet in regards to the bronchiectasis application and even then we are about 18 months away! Seems the hype is following the SP at the moment but the long-term prospects look good.

    VVS
 
watchlist Created with Sketch. Add SNT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.